CLDX Other Income/Expenses (Net)
Celldex Therapeutics Inc · Other Income/Expenses (Net)
CLDX Other Income/Expenses (Net)
Latest reported$25.27Mperiod ending
CLDX TTM Other Income/Expenses (Net) ($1.70M → $25.27M)
TTM Other Income/Expenses (Net)
High-resolution chart · PNG
CLDX other income/expenses (net) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Other Income/Expenses (Net) (USD) |
|---|---|
| 25,270,000 | |
| 25,407,000 | |
| 28,600,000 | |
| 31,708,000 | |
| 35,140,000 | |
| 38,358,000 | |
| 37,215,000 | |
| 32,601,000 | |
| 25,575,000 | |
| 17,803,000 | |
| 13,112,999 | |
| 10,189,999 | |
| 8,122,999 | |
| 5,811,999 | |
| 2,909,000 | |
| 1,703,000 | |
| 936,000 | |
| 611,000 | |
| 505,000 | |
| 2,255,000 | |
| 2,228,000 | |
| 2,267,000 | |
| 2,408,000 | |
| 3,008,000 | |
| 3,321,000 | |
| 3,693,000 | |
| 4,153,000 | |
| 4,332,000 | |
| 4,422,000 | |
| 4,410,000 | |
| 4,488,000 | |
| 4,370,000 | |
| 4,247,000 | |
| 4,143,000 | |
| 4,214,000 | |
| 4,156,000 | |
| 4,153,000 | |
| 4,205,000 | |
| 4,385,000 | |
| 2,594,000 | |
| 2,590,000 | |
| 2,567,000 | |
| 2,343,000 | |
| 1,818,000 | |
| 3,687,000 | |
| 3,571,000 | |
| 4,350,000 | |
| 4,173,000 | |
| 2,042,000 | |
| 1,409,000 | |
| -108,000 | |
| -417,000 | |
| -822,000 | |
| -749,000 | |
| -1,046,000 | |
| -1,146,000 | |
| -1,164,000 | |
| 9,002,000 | |
| 18,888,000 | |
| 15,864,000 | |
| 25,037,000 | |
| 24,442,000 | |
| 24,191,000 | |
| -9,564,487 | |
| -11,287,487 | |
| -20,555,487 | |
| -22,176,487 | |
| -47,475,129,371 | |
| -47,481,363,551 | |
| -47,481,282,360 | |
| -47,489,022,106 | |
| 1,224,263 | |
| -893,777 | |
| 1,846,328 | |
| 1,970,806 | |
| 2,368,192 | |
| 4,188,743 | |
| 2,003,538 | |
| 2,113,327 | |
| -18,095,535,750 | |
| -18,096,010,419 | |
| -18,096,406,599 | |
| -18,096,535,991 | |
| 668,402 | |
| 4,336,388 | |
| 4,172,977 | |
| 5,985,264 | |
| 5,929,264 | |
| 2,163,416 | |
| 2,081,116 | |
| 239,800 | |
| 301,300 | |
| 370,800 | |
| 521,200 | |
| 602,600 | |
| 760,800 | |
| 997,200 | |
| 1,329,400 | |
| 1,808,300 | |
| 1,534,900 |